ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MXCT Maxcyte Inc

342.50
-2.50 (-0.72%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.50 -0.72% 342.50 335.00 350.00 345.00 342.50 345.00 24,274 16:17:54
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 44.26M -23.57M -0.2277 -18.40 433.68M
Maxcyte Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker MXCT. The last closing price for Maxcyte was 345p. Over the last year, Maxcyte shares have traded in a share price range of 172.50p to 430.00p.

Maxcyte currently has 103,504,571 shares in issue. The market capitalisation of Maxcyte is £433.68 million. Maxcyte has a price to earnings ratio (PE ratio) of -18.40.

Maxcyte Share Discussion Threads

Showing 26 to 49 of 1475 messages
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
16/3/2017
10:41
Maxcyte CEO Doug Doerfler will be presenting to investors at the upcoming Proactive One2One Forum taking place on the evening of 23rd March in Mayfair, London. For details and registration, please click here:
aim_trader
14/3/2017
18:18
I thought they might go a bit higher today on the back of that news, so I'll save the the next rocket for a better day, meanwhile there's a new interview with Doug Doerfler on Proactive investor which is well worth a listen:



in response to a question on why do they (i.e. big biotech) come to MaxCyte? DD states in his response:

.......we can deliver any molecule to any cell at any scale and we do it highly efficiently, high performance and we also do it in a clinical setting so it can be used to modify those cells to engineer cells and return those cells to the patient and we are the only group who can do that clinically......"

Which goes some way to explain why the shares are in such demand

timbo003
14/3/2017
08:41
Time for another Rocket video clip Tim?
davep4
14/3/2017
08:23
New Trinity Delta Research note now out following today's announcement:
timbo003
10/3/2017
22:53
MaxCyte will be presenting at the Proactive investor evening on Thursday March 23rd, I plan to attend and will report back in due course:
timbo003
13/2/2017
10:14
Mornin' ali

I find it impossible to value this one, I bought primarily for the tax breaks as you know. I dont really believe in reading tea leaves, but I suspect the chartists would have said it was overdue a big correction at 280p, mind you they would probably have told you the same thing at 140p and 210p on the way up (and it didnt happen). This is one share where I havent been able to talk to the ,management, so all I have to go on is what is in the public domain.

The Trinity Development research notes are a useful read if you haven't already seen them

timbo003
12/2/2017
12:13
hi timbo

you probably have studied this one thoroughly- i have been watching it and i notice it is down 30pc- but no clue as to whether this presents an opportunity to enter? just interested in your take!

ali47fish
07/2/2017
14:25
Let sleeping dogs lie timbo003!
davep4
06/2/2017
17:40
This is now a 4 bagger since the IPO, or a 5.5 bagger if you take into account the EIS tax relief.

I find it quite extraordinary that there is no interest here. I would have thought at least the Scancell crowd might have had a sniff around, given that MaxCyte's business is all about Electroporation and Scancell's lead drug (SCIB1) requires electroporation for effective delivery.

timbo003
27/1/2017
16:35
Here's a date for your diaries

23rd March MaxCyte will be presenting at the Proactiveinvestor evening at the Chesterfield Hotel in Mayfair,

It's free and you get fed and watered afterwards, so I've booked my place.

timbo003
26/1/2017
17:29
Another good day, market cap now just a tad over £100m, presumably it will now get on a few more radar screens.
timbo003
25/1/2017
08:02
Thanks for that dave4p, there is also a new note available from Trinity Delta here:
timbo003
12/1/2017
08:21
The publication referred to in today's RNS appears to concern the work referred to in Panmure Gordon's morning note from last week.

Up again today, now 3X the IPO price, or over 4X the price paid by IPO participants who qualified for EIS tax reliefs (i.e. 49p/share).

timbo003
11/1/2017
09:02
Yes and from memory 50+ licencees,(up from 30+ at the time of the float).
davep4
11/1/2017
08:38
Thanks Dave4p

That note from Panmure puts the rise into context, so they are now looking at a new platform which is likely to be of considerable interest to big pharma and it sounds like Maxcyte are the only shop in town

timbo003
10/1/2017
14:10
And the following update by PG:
davep4
06/1/2017
19:59
Thanks leedskier

Found it:

timbo003
06/1/2017
15:25
The Ft has named it as the top pharma small cap stock pick of 2017.
leedskier
06/1/2017
10:06
Up today again and I am still none the wiser

There is nothing obvious on their twitter feed, other than they will be presenting at Biotech show case next week which surely wouldn't account for this rise

timbo003
05/1/2017
11:26
Time for another animated gif!

I have no idea why these are up today, or why no one else in the ADVFN and LSE cyber communities have shown any interest in this one, but I am quite happy to be a Norman no mates if the performance continues like this

timbo003
22/12/2016
05:41
New video of CEO Doug Doerfler discussing the latest announcement regarding MaxCytes's CARMA platform:
timbo003
29/11/2016
09:56
don't worry timbo it will soon drift back down again
jinky2
29/11/2016
08:56
Drifting up for no easily discernable reason, normally my AIM shares do the opposite in the absence on news. If only they were all like this one (sigh!)
timbo003
28/10/2016
07:35
>>davep4, indeed. I wish I had as much in this one as have in Cyan. I seem to have an exceptional talent for underinvesting in shares which take off like this one!
timbo003
Chat Pages: Latest  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock